#142: Chad Kerksick - Dileucine, Dihydroberberine, & GLP-1 Research (2 of 2)

The PricePlow Podcast

Το περιεχόμενο παρέχεται από το Supplement Industry Thought Leaders. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον Supplement Industry Thought Leaders ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.

3M ago 1:00:21

MP3•Αρχική οθόνη επεισοδίου

In Episode 142 of the PricePlow Podcast, Mike and Ben continue the conversation with Chad Kerksick, President of the International Society of Sports Nutrition (ISSN). We met Chad in Episode #141 — he’s an esteemed researcher in exercise science and nutrition. This episode delves deeper into the specifics of study design and the exploration of innovative ingredients in the supplement industry, namely NNB Nutrition’s RAMPS Dileucine (DL185) and GlucoVantage Dihydroberberine.

In this continuation, the focus shifts to the practical applications of Chad’s research and his insights into the latest trends and advancements in sports nutrition.

Chad kicks off the discussion by recounting his initial experiences with study design. He emphasizes the need for careful consideration to avoid common pitfalls and ensure the validity of the findings.

RAMPS Dileucine and GlucoVantage Dihydroberberine

The conversation then transitions to specific ingredients, with a spotlight on NNB Nutrition’s RAMPS Dileucine (DL185) and GlucoVantage Dihydroberberine. Chad shares his experiences with these compounds, discussing their potential benefits and the nuances of incorporating them into research studies. He provides valuable insights into the challenges and opportunities of working with novel ingredients, offering practical advice for both researchers and industry professionals.

GLP-1 Agonists

One of the key highlights of this episode is the discussion on targeting new areas of research, particularly GLP-1 agonists. Chad explores the potential of these compounds in weight management and metabolic health, drawing parallels with existing pharmaceutical interventions and the quest for natural alternatives. He outlines the steps involved in designing effective studies to evaluate these ingredients, emphasizing the importance of understanding their mechanisms of action and physiological impacts.

Throughout the episode, Chad’s expertise shines through as he navigates complex topics with ease, providing listeners with knowledge and practical takeaways. Whether you’re a researcher, a supplement industry professional, or simply a health enthusiast, this episode is packed with information and insights.

https://blog.priceplow.com/podcast/chad-kerksick-dileucine-dihydroberberine-glp-142

Video: Chad Kerksick Researches Dileucine, Dihydroberberine, and GLP-1

https://www.youtube.com/watch?v=JWH9rJ-sIbM

Show Notes with Chad Kerksick – Part 2 of 2

(0:00) – Chad Kerksick Pt. 2
(5:00) – Defining Terms: “Trained Individual”
(12:00) – Understanding Ingredients
(17:45) – Study design around dileucine
(24:00) – Simplifying training regimens
(30:58) – Formulating a supplement with dileucine
(36:15) – Training for the study
(43:15) – Berberine’s potential
(48:30) – Measuring appetite
(54:15) – Dihydroberberine

Where to Find Chad Kerksick Online

Instagram: @ChadKerksick
LinkedIn: linkedin.com/in/chadkerksick/
ISSN Website:…<…